Instil Bio, Inc.
TIL
$7.96
-$0.02-0.25%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -11.73% | 2.80% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -37.03% | -36.38% | |||
| Operating Income | 37.03% | 36.38% | |||
| Income Before Tax | 48.68% | 39.71% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 48.68% | 39.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 48.68% | 39.71% | |||
| EBIT | 37.03% | 36.38% | |||
| EBITDA | 37.08% | 36.41% | |||
| EPS Basic | 48.68% | 39.93% | |||
| Normalized Basic EPS | 41.01% | 39.93% | |||
| EPS Diluted | 48.68% | 39.93% | |||
| Normalized Diluted EPS | 41.01% | 39.93% | |||
| Average Basic Shares Outstanding | 0.00% | 0.36% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||